Inducible	0	9	B-Gene_or_gene_product
nitric	10	16	I-Gene_or_gene_product
oxide	17	22	I-Gene_or_gene_product
synthase	23	31	I-Gene_or_gene_product
modulates	32	41	O
angiogenesis	42	54	O
in	55	57	O
ischemic	58	66	O
hindlimb	67	75	B-Organism_subdivision
of	76	78	O
rat	79	82	B-Organism
.	82	83	O

BACKGROUND	85	95	O
:	95	96	O
Angiogenesis	97	109	O
plays	110	115	O
an	116	118	O
important	119	128	O
role	129	133	O
in	134	136	O
maintaining	137	148	O
adequate	149	157	O
oxygen	158	164	B-Drug_or_compound
delivery	165	173	O
,	173	174	O
and	175	178	O
nitric	179	185	B-Drug_or_compound
oxide	186	191	I-Drug_or_compound
(	192	193	O
NO	193	195	B-Drug_or_compound
)	195	196	O
is	197	199	O
a	200	201	O
potential	202	211	O
regulator	212	221	O
of	222	224	O
angiogenesis	225	237	O
.	237	238	O

NO	239	241	B-Drug_or_compound
is	242	244	O
synthesized	245	256	O
through	257	264	O
three	265	270	O
isoforms	271	279	O
of	280	282	O
NO	283	285	B-Gene_or_gene_product
synthase	286	294	I-Gene_or_gene_product
(	295	296	O
NOS	296	299	B-Gene_or_gene_product
)	299	300	O
.	300	301	O

It	302	304	O
is	305	307	O
hypothesized	308	320	O
that	321	325	O
the	326	329	O
NO	330	332	B-Drug_or_compound
derived	333	340	O
from	341	345	O
inducible	346	355	B-Gene_or_gene_product
NOS	356	359	I-Gene_or_gene_product
(	360	361	O
iNOS	361	365	B-Gene_or_gene_product
)	365	366	O
may	367	370	O
promote	371	378	O
survival	379	387	O
of	388	390	O
ischemic	391	399	B-Tissue
tissue	400	406	I-Tissue
through	407	414	O
angiogenesis	415	427	O
.	427	428	O

To	429	431	O
test	432	436	O
this	437	441	O
hypothesis	442	452	O
,	452	453	O
we	454	456	O
investigated	457	469	O
the	470	473	O
effect	474	480	O
of	481	483	O
iNOS	484	488	B-Gene_or_gene_product
deficiency	489	499	O
(	500	501	O
by	501	503	O
L	504	505	B-Drug_or_compound
-	505	506	I-Drug_or_compound
NIL	506	509	I-Drug_or_compound
)	509	510	O
on	511	513	O
angiogenesis	514	526	O
in	527	529	O
a	530	531	O
hindlimb	532	540	B-Organism_subdivision
ischemia	541	549	O
model	550	555	O
.	555	556	O

METHODS	557	564	O
:	564	565	O
Thirty	566	572	O
-	572	573	O
two	573	576	O
male	577	581	O
wistar	582	588	B-Organism
rats	589	593	I-Organism
randomly	594	602	O
divided	603	610	O
into	611	615	O
four	616	620	O
groups	621	627	O
.	627	628	O

In	629	631	O
groups	632	638	O
1	639	640	O
&	641	642	O
2	643	644	O
,	644	645	O
hindlimb	646	654	B-Organism_subdivision
ischemia	655	663	O
was	664	667	O
induced	668	675	O
by	676	678	O
ligation	679	687	O
of	688	690	O
femoral	691	698	B-Multi-tissue_structure
artery	699	705	I-Multi-tissue_structure
and	706	709	O
they	710	714	O
received	715	723	O
L	724	725	B-Drug_or_compound
-	725	726	I-Drug_or_compound
NIL	726	729	I-Drug_or_compound
and	730	733	O
saline	734	740	B-Drug_or_compound
respectively	741	753	O
.	753	754	O

The	755	758	O
animals	759	766	O
in	767	769	O
groups	770	776	O
3	777	778	O
and	779	782	O
4	783	784	O
also	785	789	O
received	790	798	O
L	799	800	B-Drug_or_compound
-	800	801	I-Drug_or_compound
NIL	801	804	I-Drug_or_compound
and	805	808	O
saline	809	815	B-Drug_or_compound
respectively	816	828	O
without	829	836	O
surgical	837	845	O
procedure	846	855	O
.	855	856	O

After	857	862	O
21	863	865	O
days	866	870	O
,	870	871	O
the	872	875	O
serum	876	881	B-Organism_substance
concentration	882	895	O
of	896	898	O
nitrite	899	906	B-Drug_or_compound
,	906	907	O
capillary	908	917	B-Tissue
density	918	925	O
and	926	929	O
expression	930	940	O
of	941	943	O
HIF1alpha	944	953	B-Gene_or_gene_product
were	954	958	O
determined	959	969	O
.	969	970	O

RESULTS	971	978	O
:	978	979	O
Serum	980	985	B-Organism_substance
nitrite	986	993	B-Drug_or_compound
levels	994	1000	O
were	1001	1005	O
significantly	1006	1019	O
lower	1020	1025	O
in	1026	1028	O
L	1029	1030	B-Drug_or_compound
-	1030	1031	I-Drug_or_compound
NIL	1031	1034	I-Drug_or_compound
groups	1035	1041	O
(	1042	1043	O
p	1043	1044	O
<	1044	1045	O
0	1045	1046	O
.	1046	1047	O
05	1047	1049	O
)	1049	1050	O
.	1050	1051	O

The	1052	1055	O
capillary	1056	1065	B-Tissue
density	1066	1073	O
in	1074	1076	O
group	1077	1082	O
1	1083	1084	O
(	1085	1086	O
ischemia	1086	1094	O
+	1094	1095	O
L	1095	1096	B-Drug_or_compound
-	1096	1097	I-Drug_or_compound
NIL	1097	1100	I-Drug_or_compound
)	1100	1101	O
was	1102	1105	O
significantly	1106	1119	O
different	1120	1129	O
from	1130	1134	O
group	1135	1140	O
2	1141	1142	O
(	1143	1144	O
ischemia	1144	1152	O
+	1152	1153	O
saline	1153	1159	B-Drug_or_compound
)	1159	1160	O
;	1160	1161	O
group	1162	1167	O
1	1168	1169	O
:	1169	1170	O
360	1171	1174	O
.	1174	1175	O
33	1175	1177	O
+	1177	1178	O
/	1178	1179	O
-	1179	1180	O
77	1180	1182	O
.	1182	1183	O
02	1183	1185	O
,	1185	1186	O
group	1187	1192	O
2	1193	1194	O
:	1194	1195	O
549	1196	1199	O
+	1199	1200	O
/	1200	1201	O
-	1201	1202	O
81	1202	1204	O
.	1204	1205	O
85	1205	1207	O
/	1208	1209	O
mm2	1209	1212	O
,	1212	1213	O
p	1214	1215	O
<	1215	1216	O
0	1216	1217	O
.	1217	1218	O
05	1218	1220	O
)	1220	1221	O
.	1222	1223	O
In	1223	1225	O
addition	1226	1234	O
,	1234	1235	O
expression	1236	1246	O
of	1247	1249	O
HIF1alpha	1250	1259	B-Gene_or_gene_product
was	1260	1263	O
significantly	1264	1277	O
increased	1278	1287	O
in	1288	1290	O
ischemic	1291	1299	O
groups	1300	1306	O
(	1307	1308	O
p	1308	1309	O
<	1309	1310	O
0	1310	1311	O
.	1311	1312	O
05	1312	1314	O
)	1314	1315	O
.	1315	1316	O

CONCLUSION	1317	1327	O
:	1327	1328	O
Selective	1329	1338	O
inhibition	1339	1349	O
of	1350	1352	O
iNOS	1353	1357	B-Gene_or_gene_product
by	1358	1360	O
L	1361	1362	B-Drug_or_compound
-	1362	1363	I-Drug_or_compound
NIL	1363	1366	I-Drug_or_compound
inhibits	1367	1375	O
angiogenesis	1376	1388	O
in	1389	1391	O
a	1392	1393	O
hindlimb	1394	1402	B-Organism_subdivision
ischemic	1403	1411	O
rat	1412	1415	B-Organism
model	1416	1421	O
.	1421	1422	O

In	1423	1425	O
addition	1426	1434	O
,	1434	1435	O
ischemia	1436	1444	O
induces	1445	1452	O
expression	1453	1463	O
of	1464	1466	O
HIF1alpha	1467	1476	B-Gene_or_gene_product
in	1477	1479	O
hypoxic	1480	1487	B-Tissue
tissue	1488	1494	I-Tissue
.	1494	1495	O

